We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
SPX Corp
SPXC
$8.95B
| $319K | 0.01% |
11,703
+2,232
| +24% | +$58K |
|
852
Avnet
AVT
$7.61B
| $316K | ﹤0.01% |
7,137
-1,229
| -15% | -$54.1K |
|
|
MWV
853
DELISTED
MEADWESTVACO CORP
MWV
| $316K | ﹤0.01% |
7,150
-43
| -0.6% | -$1.75K |
|
|
URS
854
DELISTED
URS CORP
URS
| $312K | ﹤0.01% |
6,810
-207,996
| -97% | -$9.61M |
|
855
Cenovus Energy
CVE
$60B
| $309K | ﹤0.01% |
9,537
+1,999
| +27% | +$59.5K |
|
|
ACC
856
DELISTED
American Campus Communities, Inc.
ACC
| $304K | ﹤0.01% |
+7,956
| New | +$305K |
|
857
Incyte
INCY
$25.3B
| $303K | ﹤0.01% |
5,375
-220
| -4% | -$11.2K |
|
858
Equinix
EQIX
$100B
| $302K | ﹤0.01% |
+1,437
| New | +$277K |
|
859
Jacobs Solutions
J
$16.8B
| $302K | ﹤0.01% |
6,846
+2,150
| +46% | +$102K |
|
860
Macy's
M
$5.7B
| $302K | ﹤0.01% |
5,208
+761
| +17% | +$44.2K |
|
861
Zurn Elkay Water Solutions
ZWS
$7.61B
| $301K | ﹤0.01% |
+22,192
| New | +$295K |
|
862
Motorola Solutions
MSI
$76.2B
| $300K | ﹤0.01% |
4,511
+200
| +5% | +$13.2K |
|
863
H.B. Fuller
FUL
$2.73B
| $299K | ﹤0.01% |
+6,223
| New | +$298K |
|
864
Xylem
XYL
$25B
| $299K | ﹤0.01% |
+7,640
| New | +$285K |
|
865
ITT
ITT
$17.4B
| $298K | ﹤0.01% |
6,190
-625
| -9% | -$27.8K |
|
|
BEAV
866
PUT
DELISTED
B/E Aerospace Inc
BEAV
| $291K | ﹤0.01% |
+63,802
| New | +$4.25M |
|
867
PUT
JetBlue
JBLU
$1.62B
| $290K | ﹤0.01% |
+464,300
| New | +$4.29M |
|
868
Flotek Industries
FTK
$1.02B
| $289K | ﹤0.01% |
+1,499
| New | +$263K |
|
869
ManpowerGroup
MAN
$2.69B
| $288K | ﹤0.01% |
3,391
-1,241
| -27% | -$101K |
|
|
BGC
870
DELISTED
General Cable Corporation
BGC
| $287K | ﹤0.01% |
11,190
-13,578
| -55% | -$341K |
|
|
DCOM
871
DELISTED
Dime Community Bancshares
DCOM
| $287K | ﹤0.01% |
+18,184
| New | +$289K |
|
872
Booz Allen Hamilton
BAH
$9.43B
| $286K | ﹤0.01% |
+13,483
| New | +$305K |
|
|
AFOP
873
DELISTED
Alliance Fiber Optic Prod Inc
AFOP
| $286K | ﹤0.01% |
+15,828
| New | +$299K |
|
|
TRW
874
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| $286K | ﹤0.01% |
3,200
+240
| +8% | +$20K |
|
|
SD
875
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $285K | ﹤0.01% |
+39,870
| New | +$268K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.